TSX Delisting Review - SemBioSys Genetics Inc. (SBS)

TORONTO, Oct 7 /CNW/ - DELISTING REVIEW SemBioSys Genetics Inc. (the "Company") - TSX is reviewing the Common Shares (Symbol: SBS) of the Company with respect to meeting the continued listing requirements.  The Company has been granted 60 days in which to regain compliance with these requirements, pursuant to the Remedial Review Process.

About TMX Group

TMX Group's key subsidiaries operate cash and derivative markets for multiple asset classes including equities, fixed income and energy. Toronto Stock Exchange, TSX Venture Exchange, Montreal Exchange, Natural Gas Exchange, Boston Options Exchange (BOX), Shorcan, Equicom and other TMX Group companies provide trading markets, clearing facilities, data products and other services to the global financial community. TMX Group is headquartered in Toronto with offices in Montreal, Calgary and Vancouver.  For more information about TMX Group, visit our website at www.tmx.com.

For further information:

Corporate Communications, TMX Group Inc., Toll Free 1-888-873-8392, [email protected].